Treatment of facial myokymia in multiple sclerosis with botulinum toxin

Acta Neurol Belg. 2012 Dec;112(4):423-4. doi: 10.1007/s13760-012-0092-3. Epub 2012 Jun 5.

Authors

Mario Habek¹, Ivan Adamec, Tereza Gabelić, Vesna V Brinar

Affiliation

¹ Referral Center for Demyelinating Diseases of the Central Nervous System, University Department of Neurology, Zagreb School of Medicine and University Hospital Center, Kišpatićeva 12, 10000 Zagreb, Croatia. [email protected]

PMID: 22669610
DOI: 10.1007/s13760-012-0092-3

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Botulinum Toxins, Type A / therapeutic use*
Facial Nerve Diseases / complications
Facial Nerve Diseases / drug therapy*
Facial Nerve Diseases / pathology
Humans
Magnetic Resonance Imaging
Male
Multiple Sclerosis / complications
Multiple Sclerosis / pathology*
Neuromuscular Agents / therapeutic use*
Pons / pathology*
Treatment Outcome

Substances

Neuromuscular Agents
Botulinum Toxins, Type A